CAR-T Cells/-NK cells in cancer immunotherapy and the potential of MSC to enhance its efficacy: a review
The chimeric antigen receptor (CAR) plays a dynamic role in targeting tumour-associated antigens in cancer cells. This novel therapeutic discovery combines fragments of monoclonal antibodies with the signalling and co-stimulatory domains that have been modified to its current fourth generation. CAR...
Saved in:
Main Authors: | Chan, Ler Yie, Dass, Sylvia Annabel, Tye, Gee Jun, Imran, Siti A. M., Wan Kamarul Zaman, Wan Safwani, Nordin, Fazlina |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/42916/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MSCs vs. iPSCs: Potential in therapeutic applications
by: Thanaskody, Kalaiselvaan, et al.
Published: (2022) -
Explorations of CRISPR/Cas9 for improving the long-term efficacy of universal CAR-T cells in tumor immunotherapy
by: Muhammad Naeem, Muhammad Naeem, et al.
Published: (2023) -
Non-integrating Lentiviral vectors in clinical applications: A glance through
by: Gurumoorthy, Narmatha, et al.
Published: (2022) -
Dendritic cell immunobiology and potential roles in immunotherapy
by: Fadilah, S.A.W., et al.
Published: (2007) -
Diving deep into fish allergen immunotherapy: Current knowledge and future directions
by: Kavita, Reginald *, et al.
Published: (2024)